News

The project benefits from a C$1.5 million grant from Médicament Québec (MQ), an initiative supported by the Ministère de l'Économie, de l'Innovation et de l'Énergie (MEIE). MQ's mission is to strengthen the autonomy and dynamism of Quebec and Canada in bioinnovation and biomanufacturing. The project will be carried out in collaboration with Professor Bruno Gaillet (Université Laval), director of activities, and TransBIOTech.

CQDM is proud to announce the funding of two collaborative research projects related to the development of RNA therapies. This announcement marks the awarding of financial support totalling $700,844, granted by the Quebec government via CQDM's SynergiQc program. These two projects are examples of the exceptional vitality of Quebec's biotechnology ecosystem and the inventiveness of its researchers.

Molecular Forecaster Inc (MFI) and TransBIOTech are pleased to announce a strategic partnership that leverages the complementary strengths of both organizations to develop drug discovery programs combining MFI's customized computer-aided design (CADD) solutions with TransBIOTech's in vitro and in vivo expertise.